Literature DB >> 21556864

Inflammatory myopathy in a patient with postural and kinetik tremor.

Daniele Orsucci1, Michelangelo Mancuso, Greta Alì, Valeria Calsolaro, Giulia Ricci, Sara Gori, Gabriele Siciliano.   

Abstract

Essential tremor (ET) is a common neurological disease of unknown etiopathogenesis, possibly neurodegenerative, characterized by kinetic tremor at the arms. Here we reported the case of an HCV-positive patient with inflammatory myopathy, who did not develop typical neuromuscular signs or symptoms during at least 7 years of hyperCKemia, in whom kinetic tremor of the arms was the prominent clinical feature, suggesting a possible diagnosis of ET. After 3 months of treatment with corticosteroids/methotrexate, creatine kinase (CK) levels were nearly normal and the tremor was remarkably improved. To our knowledge, similar cases have not been previously reported. Postural tremor can be present in muscular diseases, but only very rarely tremor has been reported as a major clinical feature. Because inflammatory myopathies are potentially treatable conditions it is very important to consider this diagnosis. Our case suggests that in patients with isolated postural and kinetic tremor routine laboratory assays should include CK blood screening.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556864     DOI: 10.1007/s10072-011-0615-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

Review 1.  Essential tremor.

Authors:  Elan D Louis
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

2.  Mitochondrial DNA single deletion in a patient with postural tremor.

Authors:  Michelangelo Mancuso; Daniele Orsucci; Sara Gori; Roberto Ceravolo; Gabriele Siciliano
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

3.  Inclusion body myositis associated with a severe unilateral levodopa-responsive upper extremity tremor.

Authors:  K J Felice; M L Grunnet
Journal:  Muscle Nerve       Date:  1996-06       Impact factor: 3.217

4.  EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia.

Authors:  T Kyriakides; C Angelini; J Schaefer; S Sacconi; G Siciliano; J J Vilchez; D Hilton-Jones
Journal:  Eur J Neurol       Date:  2010-04-05       Impact factor: 6.089

5.  The effects of unilateral muscle fatigue on bilateral physiological tremor.

Authors:  S Morrison; J Kavanagh; S J Obst; J Irwin; L J Haseler
Journal:  Exp Brain Res       Date:  2005-08-03       Impact factor: 1.972

6.  Atypical Parkinsonism in distal myopathy with rimmed vacuoles.

Authors:  Tomohiko Ishihara; Tetsutaro Ozawa; Shuichi Igarashi; Yuko Kitsukawa; Masahito Takagi; Masaki Hirose; Takayoshi Tokutake; Keiko Tanaka; Masatoyo Nishizawa
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

7.  Distribution of creatine kinase in the general population: implications for statin therapy.

Authors:  Lizzy M Brewster; Gideon Mairuhu; August Sturk; Gert A van Montfrans
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

8.  Evaluation of postural tremor of finger for neuromuscular diseases and its application to the classification.

Authors:  H Makabe; K Sakamoto
Journal:  Electromyogr Clin Neurophysiol       Date:  2002-06

9.  Postural tremor in X-linked spinal and bulbar muscular atrophy.

Authors:  Ritsuko Hanajima; Yasuo Terao; Setsu Nakatani-Enomoto; Masashi Hamada; Akihiro Yugeta; Hideyuki Matsumoto; Tomotaka Yamamoto; Shoji Tsuji; Yoshikazu Ugawa
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 10.  Idiopathic inflammatory myopathies.

Authors:  V S Limaye; P Blumbergs; P J Roberts-Thomson
Journal:  Intern Med J       Date:  2009-03       Impact factor: 2.048

View more
  1 in total

1.  A Case Report of Coronavirus Disease 2019 Presenting with Tremors and Gait Disturbance.

Authors:  Sharon Klein; Frederick Davis; Adam Berman; Shruti Koti; John D'Angelo; Nancy Kwon
Journal:  Clin Pract Cases Emerg Med       Date:  2020-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.